Zentiva Revenue and Competitors

Prague 10,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Zentiva's estimated annual revenue is currently $784.9M per year.(i)
  • Zentiva's estimated revenue per employee is $201,000

Employee Data

  • Zentiva has 3905 Employees.(i)
  • Zentiva grew their employee count by 8% last year.

Zentiva's People

NameTitleEmail/Phone
1
CFO GermanyReveal Email/Phone
2
CFO GermanyReveal Email/Phone
3
CEOReveal Email/Phone
4
Head Regulatory Life Cycle ManagemenReveal Email/Phone
5
Production OfficerReveal Email/Phone
6
Head Franchises & Value added Medicine D-CHReveal Email/Phone
7
Head Quality Control [AMG §12]Reveal Email/Phone
8
Head TaxReveal Email/Phone
9
Head Primary CareReveal Email/Phone
10
Head Business Development & New Product IntroductionReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is Zentiva?

Zentiva is a producer of high-quality affordable medicines serving patients in Europe and beyond. With a dedicated team of more than 4,500 people and a network of production sites - including flagship sites in Prague, Bucharest, and Ankleshwar - Zentiva strives to be the champion of branded and generic medicines in Europe to better support people's daily healthcare needs. At Zentiva it is our aspiration that healthcare should be a right and not a privilege. More than ever, people need better access to high-quality affordable medicines and healthcare. We work in partnership with physicians, pharmacists, wholesalers, regulators, and governments to provide the everyday solutions that we all depend on.

keywords:N/A

N/A

Total Funding

3905

Number of Employees

$784.9M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Zentiva News

2022-04-06 - Declining Stock and Decent Financials: Is The Market Wrong ...

In this article, we decided to focus on Zentiva's ROE. Return on equity or ROE is an important factor to be considered by a shareholder because...